Market Research Blog

Production and commercialization of biopharmaceutical proteins with higher therapeutic efficacy have formed a progressive landscape that continues to push the growth of plant derived proteins market. A new Future Market Insights (FMI) report forecasts that the plant derived proteins market will experience a major upturn towards 2029, reaching a value of around US$ 185 Mn. Production of three main therapeutic protein classes, including antibodies, vaccines, and replacement proteins such as albumin, insulin, growth factors, and cytokines will remain industry’s prime focus area. Plant derived proteins are recognized as natural and environmentally-sustainable than microbial and mammalian cells. Owing to these benefits, there has been an increasing demand for such proteins from biopharmaceutical companies, as raw materials for therapeutic drug production, creating an absolute opportunity for growth of the plant derived proteins market.

Future demands for automotive engine valves will be firmly driven by trends such as reduction in exhaust emissions and oil consumption, declining sulphur content in diesel fuel, and phasing out of leaded petrol. Such factors may create implications in production and design of automotive engine valves. Leading automakers will also seek newer materials for manufacturing engine valves with higher durability and greater sustenance to heat. With increasing adoption of alternative fuels, future requirements of automotive engine performance will change the dynamics of valve manufacturing.

An exclusive forecast report published by Future Market Insights anticipates that the global automotive engine valves market will soar at a steady CAGR of 5.2% during the forecast period, 2017-2022. The report also assesses that automotive engine valves worth over US$ 6.2 billion will be sold globally by the end of 2022. The steady demand for automotive engine valves will be factored by their essentiality in proper functioning of automobile engines, and their influence in enhancing the vehicle’s performance under diverse conditions.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-3473

Although, hollow valves will register a below-average demand over the next five years

While the overall sales of automotive engine valves will be incurring a steady demand through 2022, the demand for hollow valves is likely to dwindle. Compared to bimetallic and monometallic valves, hollow valves will be garnering low uptake owing to their conventional drawbacks. Tests show that performance of engines equipped with hollow valves gets lowered when hollow valve stems absorb more heat than threshold. The tendency of hollow valves to overheat and burn in the absence of adequate cooling continues to factor their declining demand. Over the forecast period, hollow valves are anticipated to reflect a subpar CAGR of 4.7%, indicating a moderate growth in demand.

We Offer tailor-made Solutions to fit Your Requirements, Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-3473

Market Taxonomy

A concise taxonomy of the global automotive engine valve market has been summarized in the table below:

Region

• North America
• Latin America
• Europe
• Japan
• APEJ
• MEA

Product Type

• Mono metallic valves
• Bimetallic valves
• Hollow valves
• Others

Vehicle Type

• Compact Passenger Cars
• Mid-sized Passenger Cars
• Premium Passenger Cars
• Luxury Passenger Cars
• Light Commercial Vehicles
• Heavy Commercial Vehicles

Material Type

• Steel
• Titanium
• Nickel Alloy
• Other Materials

Sales Channel

• OEM
• Aftermarket

Direct Purchase of this Report@ https://www.futuremarketinsights.com/checkout/3473

Key insights offered in the report

• In 2017, monometallic valves being sold in the global market will reap over US$ 1.5 billion in revenues
• Compact passenger cars will be observed as a leading vehicle segment in the market, followed by mid-sized passenger cars and light commercial vehicles
• Titanium materials are forecasted to incur sluggish CAGR through 2022
• By 2022-end, aftermarket sales of automotive engine valves will bring in revenues worth over US$ 5 billion, globally

In 2017, Europe is poised to procure nearly one-fourth share of global revenues. The report also projects that the Asia-Pacific excluding Japan (APEJ) region will be the largest market for automotive engine valves. By the end of 2022, the APEJ automotive engine valve market is anticipated to reach a value of US$ 2.2 billion. North America’s automotive engine valve market is also expected to soar at a steady CAGR, while sales of automotive engine valves in Japan will reflect a moderate growth.

Changing landscapes of automobile engineering will continue to foment considerable alterations in the manufacturing of automotive engine valves. New designs will be reviewed and tested, while conventional valves will be upgraded for boosting their performance abilities. The report observes that companies namely, Knorr-Bremse AG, FTE automotive GmbH, Hitachi Ltd., FUJI OOZX Inc., Mahle Group, Eaton Corporation Plc., Federal-Mogul Holdings Corp., Denso Corporation, Continental AG, and Delphi Automotive PLC will remain active in expansion of the global automotive engine valve market through 2022. These companies are anticipated to capture new materials and innovative production techniques to insure the valves from their existing defects.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/

Witnessing a prominent boost from the demand for high-speed racing cars, the global automotive brake valve market is set for a promising CAGR during 2022 – 2027. The sales of automotive brake valves will witness an uptick with the growing stringency of regulations to mandate anti-lock braking system (ABS) fitment in passenger cars and commercial vehicles, says a new study of Future Market Insights (FMI). Increasing sales of integrated electronic braking systems and electrohydraulic brake valves in automotive brake systems would elevate market prospects in the following years. Towards the end of forecast period, global sales of automotive brake valves are foreseen to reach in excess of US$ 8 Bn. The sales of automotive brake valves will witness an uptick with the growing stringency of regulations to mandate anti-lock braking system (ABS) fitment in passenger cars and commercial vehicles, says a new study of Future Market Insights (FMI). Increasing sales of integrated electronic braking systems and electrohydraulic brake valves in automotive brake systems would elevate market prospects in the following years. Towards the end of forecast period, global sales of automotive brake valves are foreseen to reach in excess of US$ 8 Bn.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-3436

Automotive Brake Valve Market – Key Takeaways

• Introduction and adoption of advanced vehicle security systems in passenger cars and commercial vehicles is a key factor identified to drive automotive brake valve market growth. ABS installation is projected to gather significant momentum for on-road as well as off-road vehicle fleet, over the forecast period.
• Increasing installation of ABS in all classes of passenger cars as well as commercial vehicles is augmenting demand for automotive brake valves.
• Moreover, use of advanced braking systems in high-speed racing cars that are subject to wear and tear is also expected to play a vital role in bolstering demand for automotive brake valves.
• In most cases, brake valves are procured by brake system manufacturers or assemblers. These are then fitted in brake systems of passenger cars and commercial vehicles. Efficient and proper value chain will further augment the growth of automotive brake valve market.
• Integration of electronics in brake systems and use of advanced technologies such as EBD, SSR, ESP, traction control and brake assist (BA) in ABS, further enhance the overall efficiency of vehicles, in turn, reducing the fitment of conventional brake valves. However, combinational and proportional brake valves are still used along with ABS to maintain tractive contact with the road.
• In case ABS fails or dysfunctions, vehicle’s regular braking system that comprises of combinational brake valves and proportional brake valves control braking activities of the vehicle. Moreover, in many newer vehicles valve assembly can get replaced separately from the ABS control module, thereby increasing opportunities in the aftermarket segment.

Considerably fair shelf life, and thus, low replacement rate of automotive brake valves will remain among the key factors limiting growth of the global market to a large extent, throughout forecast period.

We Offer tailor-made Solutions to fit Your Requirements, Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-3436

Automotive Brake Valve Market to Grow in Parallel with ABS Production

The global automotive brake valve market is estimated to witness decent growth over the forecast period. Rapidly growing automotive industry, especially production and sales of sports cars, is substantially boosting demand for automotive brake valves. East Asia will retain its dominance in the global automotive brake valve market owing to comparatively higher vehicle fleet, followed by South Asia and North America.

Who Is Winning?

Automotive brake valve market is identified to be consolidated, comprising of market players such as Wabtec Corporation, Master Power Brakes, and Parker Hannifin Corp. Market players forming supply contracts with local and regional automotive ancillaries are expected to drive market growth. Furthermore, tie-ups between ABS and brake valve manufacturers are fueling automotive brake valve market growth. Moreover, continual dependency of local automotive OEMs on aftermarket sales will surge demand for automotive brake valves during the forecast period.

AUTOMOTIVE BRAKE VALVES MARKET TAXONOMY

The global automotive brake valve market is segmented in detail to cover every aspect of the market and present complete market intelligence to the reader.

Product

• Combination Valves
• Quick Release Valves
• Metering Valves
• ABS Modulator Valves
• Foot & Hand Brake Valves
• Parking Brake Valves
• Emergency Valves
• Check Valves
• Spring Valves
• Proportional Valves

Vehicle

• Compact Cars
• Mid-sized
• Luxury Cars
• SUVs
• HCVs
• LCVs

Material

• Steel
• Copper
• Brass
• Alloy

Sales Channel

• OEMs
• Aftermarket

Region

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Middle East & Africa

Direct Purchase of this Report@ https://www.futuremarketinsights.com/checkout/3436

Report at Glance

The global automotive brake valves market report offers noteworthy insights and analysis for the forecast period of 2019-2027. The report includes macroeconomic factors, regional pricing analysis, market dynamics, value chain analysis, market value and volume analysis, emerging market trends, important stakeholders, list of manufacturers and distributors, industry roadmap for last five years, channel partners, and strategies deployed by market players to gain a competitive edge.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/

According to the latest research by Future Market Insights, Cognitive neuroscience market is set to witness a 4.6% CAGR growth during the year 2021-2031. The market has been a moderately competitive market developing at a rapid rate and is anticipated to observe lucrative growth with rising cases of neurological disorders that include Parkinson’s, Alzheimer’s diseases, and other dementias are projected to drive the market growth.

Also, neuroscience-based initiatives by government bodies, high influencing factors, such as current brain mapping research and investigation ventures, and technological advancements in algorithms and tools that are applied in neuroscience space, are anticipated to propel the market growth.

What is Driving Demand for Cognitive Neuroscience?

The rising number of brain-related disorders and the number of advanced healthcare systems are certain driving factors for the market.

Furthermore, key factor that has accelerated the research studies in this arena is the growth in the number of various malignant CNS disorders such as Parkinsonism and Alzheimer’s disease. As geriatric population is prone to various central nervous systems associated disorders such as schizophrenia, Alzheimer’s, and Parkinsonism, with growth in the older population, this market is anticipated to witness lucrative growth.

Ask for brochure of Market @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14154

Also, constant launch of novel products by major participants in the market to fight several neurological disorders is anticipated to increase Y-O-Y growth of this market.

Surge in Number of Deaths Due to Neurological Disorders likely to boost the Cognitive Neuroscience Sales

The rising incidents of neurological disorders, which include Parkinson’s, Alzheimer’s, and other brain-related disorders are expected to encourage participants in the cognitive neuroscience market to help combat such disorders. In 2018, over one hundred thousand people died because of Alzheimer’s in the United States.

Also, rising number of neurological disorder cases are expected to increase the number of deaths occurring due to these disorders. Moreover, the government bodies are growing the medical expenditure to support development of medical facilities in neuroscience leading to development of the market.

US and Canada Cognitive Neuroscience Market Outlook

United States and Canada led the Cognitive Neuroscience market. U.S. Cognitive Neuroscience market is anticipated to witness noteworthy growth owing the existence of neuroscience based research organizations as well as availability of advanced healthcare systems.

Moreover, large organizations and many neuroscientists are spreading knowledge and awareness through programs concerning the brain system in government as well public offices. Also, rise in number of deaths associated with neurological disorders is one of the key factors for the development of the market in U.S.

Europe Demand Outlook for Cognitive Neuroscience

Europe is second leading market and is anticipated to register a significant growth because of the growing burden of neurological diseases in Europe and the availability of large manufacturers in the region.

In 2017, as per ‘The burden of neurological diseases in Europe’ report, over a million deaths occurred in the WHO European region due to neurological diseases. It lead towards a high demand for the growth of the cognitive neuroscience market.

Who are the Key Manufacturers and Suppliers of Cognitive Neuroscience?

Some of the leading manufacturers and suppliers of cognitive neuroscience include

• Siemens Healthineers
• Scientifica Ltd.
• Alpha Omega Inc.
• GE Healthcare
• Biobserve GmbH
• NeuroNexus Technology
• Laserglow Technologies
• Kendall Research Systems LLC and others.

The cognitive neuroscience market is moderately competitive, with the existence of a large number of players in global markets. Key players in the market are focusing on mergers & acquisitions and partnerships with other small players. Moreover, companies are also concentrating on research activities and new product launches.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Cognitive Neuroscience Market Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint

Note: Although care has been taken to maintain the highest levels of accuracy in reports, recent market/vendor-specific changes may take time to reflect in the analysis.

For Complete TOC @ https://www.futuremarketinsights.com/toc/rep-gb-14154

Key Segments

By Type:

• Magnetic Resonance Imaging (MRI)
• Functional Magnetic Resonance Imaging (fMRI)
• Positron Emission Tomography (PET)
• Magnetoencephalography (MEG)
• Encephalography (EEC)
• Near Infrared Spectroscopy (NIRS)
• Single Photon Emission Computed Tomography (SPECT)

By Application:

• Brain Imaging
• Neurological Research
• Neurological Disorders
• Psychiatry

By End User:

• Pharmaceutical Companies
• Clinical & Research Laboratories
• Academic Research Institutes
• Hospitals & Pathology Laboratories
• Others

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

 

According to the latest research by Future Market Insights, HBsAg Testing market is set to witness a 5.9% growth during the year 2021-2031.

The market has been increasing at a gradual rate and is projected to witness lucrative growth due to increase in cirrhosis and liver cancer deaths due to prevalence of hepatitis B, technological advancements in diagnostic kits and due to increase in cirrhosis and growing awareness regarding early detection of hepatitis B.

What is Driving Demand for HBsAg Testing?

Hepatitis B is a potentially fatal infection and has turned into a vital healthcare problem across the world. Rise in prevalence of hepatitis B and need for early detection of hepatitis B are primary factors supporting the market growth.

In addition, rise in awareness among the population; and increase in initiatives by non-profit organizations and governments add to the development of the market. Increase in awareness among the patients’ leads to early detection of the disease. This is driving the demand for HBsAg testing.

Growing research and innovation, rise in healthcare expenditure and urbanization is resulting into rapid adoption of testing procedures, which in turn leads to market growth.

Ask for brochure of Market @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14155

Rising cases of Hepatitis B, likely to increase the HBsAg Testing Sales

Hepatitis B is an infection of worldwide importance, with a projected of 296 million people living the virus globally, according to the data provided by WHO. In the year 2019, hepatitis led to 820 000 deaths, majorly from complications such as cirrhosis and hepatocellular carcinoma.

The occurrence of hepatitis B is highest in the African and Western Pacific regions where 6.1% and 6.2% respectively of the adults are infected. Hepatitis B can lead to chronic infection and show a high risk of mortality. It is projected that 80-90% of the newborns infected with hepatitis B in first year of life suffer from chronic infections.

There is rise in prevalence of hepatitis B also because of the growing urbanization and environmental changes because of the changing lifestyle. These factors create a lucrative opportunities for hepatitis B diagnostic test manufacturers.

US and Canada HBsAg Testing Market Outlook

United States and Canada lead the HBsAg Testing market. The market is likely to witness significant growth owing to the high prevalence of acute cases of hepatitis B, availability of advanced diagnostic tools and rising awareness regarding hepatitis testing.

The rapid growth in the Canadian market is owing to the initiatives of the non-government and organizations. For example, the Public Health Agency of Canada conducted the World Hepatitis Day with the aim of growing awareness regarding hepatitis diagnosis. Thus, resulting into a demand surge for hepatitis diagnosis in the country.

Europe Demand Outlook for HBsAg Testing

Europe is second lucrative market and is likely to register a remarkable growth owing to the rising cases of hepatitis B infections, increasing diagnostic product launches, and growing healthcare expenditure in the region.

As per the World Health Organization, Hepatitis B is a contagious disease that affected approximately 15 million people in 2019 in the WHO European region. The growing geriatric population is also increasing the demand for hepatitis testing as complications associated with hepatitis worsen with aging.

Who are the Key Manufacturers and Suppliers of HBsAg Testing?

Some of the leading manufacturers and suppliers of HBsAg Testing include

• CTK Biotech Inc.
• Biopanda Reagents Ltd.
• Avecon Healthcare Pvt Ltd.
• Abbott
• Bio-Rad Laboratories Inc.
• Siemens Healthineers
• QIAGEN
• F. Hoffmann-La Roche AG and others.

The HBsAg Testing market is competitive, with the presence of a few major players. These global market players compete mainly on the basis of technological developments. Moreover, key players are investing greatly in the research and development to develop rapid and advanced diagnostic products.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

HBsAg Testing Market Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint

Note: Although care has been taken to maintain the highest levels of accuracy in reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-14155

Key Segments:

By Kit Type :

• Cassettes/Cards
• Strips

By Sample Type:

• Serum
• Plasma
• Whole Blood

By End User:

• Hospitals
• Clinics
• Diagnostic Centres
• Home Care
• Others

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

 

According to the latest research by Future Market Insights, interlaminar device market is set to witness a growth 5.4% during the year 2021-2031. Interlaminar device normally relates to the disease defined by the compression of nerve roots and shrinking of the spinal canal due to many pathologic causes, further leads to symptoms such as pain with a tingling feeling, numbness, and weakness. Spinal stenosis can include the cervical, lumbar, or thoracic (rarely) spine.

What is Driving Demand for Interlaminar Device?

The growth for interlaminar device is driven by various factors including advancements in spine surgery technologies, increasing incidence of spinal disorders, the launch of advanced bone grafting products, and the increasing adoption of minimally invasive spine surgeries.

Furthermore, key players across the globe focus on advancements in terms of technology to improve the interlaminar device efficacy and expanding their application in the market and assist with inventive growth opportunities. Furthermore, introducing unique product in the market allows businesses to acquire a competitive edge and increase product adoption.

Request for Report brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14214

Which factors are likely to Augment Growth of Interlaminar Device Market?

The growth of interlaminar device is likely to be boosted by technological factors which benefits include a shorter hospital stay and recovery time, faster and longer-lasting relief from discomfort, better treatment adaptability, and adjacent layers are naturally moving.

For instance, in May 2018 Paradigm Spine disposable instrument kit coflex® Interlaminar stabilization gets FDA pre-market approval. Coflex® interlaminar stabilization is an exclusive posterior lumbar motion preservation solution which offers long-term outcomes for patients with moderate to severe spinal stenosis.

U.S. and Canada Interlaminar Device Market Outlook

The region of North America accounts for highest market share in the current scenario for interlaminar device. The increasing adoption and penetration of interlaminar device into US and Canada market is mainly due to  a rise in the number patients with spinal cord injury, better healthcare facilities, and organizations like the North American Spine Foundation all working to raise awareness and educate healthcare providers and public about different medical condition.

As per data published by National Spinal Cord Injury Statistical Center, in 2017, approximately 285,000 people in the U.S. are estimated to be suffering from spinal cord injuries.

Europe Demand Outlook for Interlaminar Device

The European region is set to witness a dominant demand for interlaminar device due to the improving healthcare infrastructure, rising awareness, improving reimbursement scenario, and the growing insurance coverage are the major key factor to boost the growth in European region.

Some other factors are rising treatment rates for degenerative spine diseases, rising geriatric population, medical technological advances, and a growth in the demand for minimally invasive treatments are all contributing factors to this trend in Europe.

Who are the Key Manufacturers and Suppliers of Interlaminar Device?

The key companies operating in manufacturing and supply of interlaminar device market include

• NuVasive
• Life Spine
• Lanx acquired by BioMet
• X-Spine
• Pioneer Surgical
• Alphatec
• Paradigm Spine
• Spine Frontier
• Amedica Corp.
• Bioventus
• Camber Spine Technologies
• DePuy Synthes
• Implanet
• Mazor Robotics
• Meditech Spine.

The key players adopt growth strategies for product portfolio expansion by designing novel interlaminar device. The companies also have extensive distribution systems for effective sales revenue generation.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Interlaminar Device Market Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint.

Note: Although care has been taken to maintain the highest levels of accuracy in FMI’s reports, recent market/vendor-specific changes may time to reflect in the analysis.

For Complete TOC @ https://www.futuremarketinsights.com/toc/rep-gb-14214

Key Segments

By Product Type:

• Interspinous Distraction Devices
• Coflex Device

By Technology:

• Fusion and Fixation Technology
• Vertebral Compression Fracture Treatment
• Motion Preservation Technologies

By Type of Surgery:

• Open Surgery
• Minimally Invasive surgery

By End User:

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa

 

According to the latest research by FMI, portable MRI are set to witness a high growth of CAGR 6.8% during the year 2021-2031.

Portable MRI is an emerging tool during the COVID-19 pandemic. The introduction of low cost solutions in terms of portable MRI scanners is expected to enable new point-of-care and monitoring applications. With existing MRI scanners in centralized settings, accessibility and reduction of cost is primal.

Upcoming advancements in computational technology, hardware as well as expanding scanning-based technology industry in developing economies is set to effectively lead towards boosting sales of portable MRI.

Factors associated with the compatible applications of portable MRI in hospital environment and the reduced risk associated with lower magnetic strength of portable MRI are set to advance imaging services with expense mitigation, globally.

Portable MRI sales are expected to greater expansion over the forecast period owing to the strength of the factors mentioned above.

Ask for brochure of Market @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14215

What is Driving Demand for Portable MRI?

The demand for portable MRI is driven by the premise of expansive reach of MRI through cost reduction. The applications of portable MRI provide support in terms of cost, sitting and operational burdens which is directly applicable to benefitting the overall healthcare development by increasing the access to MRI examinations for a larger number of patients. Additionally, portable MRI yields a higher rate of use with varied applications.

Not to mention, in cases of acute neurological settings, the application of portable MRI will positively impact patient health with non-invasive and time-sensitive neuroimaging. The benefits of this approach can potentially be employed in the assessment of neurological injury in various medical setups, including environments with limited resources.

Which Factors are likely to Augment Growth of Portable MRI?

Technological advancements in terms of MRI scanners, especially specialty scanners has introduced a unique method of imaging. The costs associated with such scanners exhibited sub-optimal commercialization as compared to the prevailing models. The augmentative factor which provides leverage to portable MRI sales is the ease of access and potential for commercialization because of the advent of the COVID-19 pandemic.

U.S. and Canada Portable MRI Outlook

Introduction of COVID-19 pandemic over the globe impacted the magnetic resonance departments across the United States in terms of reduced procedure volume. The region of North America is expected to exhibit growth in terms of portable MRI sales over the forecast period. The growth is catalyzed by the increasing patient pool in the region as well globally, and rising awareness towards early diagnosis of diseases.

To quote health information provided by the Govt. of Canada on their website “44% of adults 20+ have at least 1 of 10 common chronic conditions”. Portable MRI demand in Canada is expected to increase over the forecast period owing to the rising prevalence of chronic diseases and growing geriatric population.

Europe Demand Outlook for Portable MRI

The region of Europe is projected to occupy a large share after North America in the adoption of portable MRI due to the rising prevalence of chronic diseases in the region, as well as increasing technological advancements, resulting in high demand for medical imaging devices.

The growth is also associated with the growing popularity of teleconsultation and teleradiology in the region, especially in countries like Germany. Demand of portable MRI in the region is lucrative and based upon the premise to fight cancer by employing cost-efficient and accessible diagnostic imaging solutions.

Who are the Key Manufacturers and Suppliers of Portable MRI?

Key companies operating in manufacturing and supply of Portable MRI are

• GE Healthcare
• Siemens Healthineers
• Philips Healthcare
• Canon Medical Systems
• Hyperfine
• Voxelgrids
• PrizMed Imaging.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Portable MRI market Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint.

Note: Although care has been taken to maintain the highest levels of accuracy in FMI’s reports, recent market/vendor-specific changes may time to reflect in the analysis.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-14215

Key Segments

By Type:

• Superconducting-magnet-based portable MRI
• Electromagnet-based portable MRI
• Permanent-magnet-based portable MRI

By Imaging:

• General Brain Imaging
• Headaches
• Stroke
• Non-Specific Muscular Weakness
• Encephalopathy

By Facility

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Research Laboratories

By Region:

• North America
  • US
  • Canada
• Latin America
  • Brazil
  • Mexico
• Europe
  • Germany
  • Italy
  • France
  • U.K.
  • Spain
  • BENELUX
  • Russia
• South Asia
  • India
  • Thailand
  • Malaysia
  • Indonesia
  • Rest of South Asia
• East Asia

• China
• Japan
• South Korea

• Middle East and Africa
  • GCC Countries
  • South Africa
  • Turkey

 

According to the latest research by FMI, EMG biosensors market is set to experience steady growth during the year 2021-2031. With increasing importance of continuous health monitoring, the market according to research conducted by Fact.MR will see a steady growth over the forecast period of 2021-2031 with a CAGR of around 6.7%.

What is Driving the Demand for EMG Biosensors market?

Skeletal muscles in the human body carry out their function of contracting and relaxing with help of electrical signals directed by the brain. EMG or Electromyograph is type of device that measure this electrical activity.

Any variation in these patterns can point to a disturbance in the standard muscular function. This activity can be widely measured and analysed in two forms; pattern recognition and signal intensity.

Abnormal pattern in the former can indicate towards a potential muscular complication. The later, however, helps in determining the strength of the electrical signals reaching the muscles from the brain. Low signal points towards a probable electrical conduction issue in these skeletal muscles and vice versa.

Request for Report brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14216

These biosensors apart from EMG have diversity in their application, ranging from monitoring of heart rate, neural study and dermal study. This is an important factor in driving this market towards an optimistic future.

Growing awareness of continuous health monitoring is another crucial factor in driving this market ahead. This has recently gained more popularity among the athletes. Many athletes use this EMG biosensors to closely monitor their health, and notifies them in case of health concerns. This early detection will help athletes perform better and help them stay ahead of their game.

With technological advancements, biosensor technology is integrated in smart bands, smart watches, and smart rings which help monitor health parameters on the move 24/7. Although this may open up new avenues, but data accuracy is one of the concern which is likely to have negative impact on the market growth.

Development of Novel EMG Biosensors to Create lucrative Growth Opportunities.

According to article published by American Institute of Physics in their APL Materials journal (24 August 2021) use of nanocomposites made from materials like gold and silver which can be used in EMG biosensors.

Textile-based and affordable silver (Ag) micro-flakes were fabricated and then gold (Au) nano-particles were electrochemically deposited on the Ag. This process helped the researchers in increasing the bioavailability, biocompatibility and surface area of the particles.

It was inferred that the signals received during the myography were detected with more ease and accuracy than the normal biosensors. Bicep and finger movements were recorded to show the most sensitivity among other movements. Discoveries like these venturing into novel avenues to improve existing infrastructure will reinforce the growth of EMG biosensors market.

U.S and Canada EMG Biosensors Market

Advanced health edifice combined with standardized policies will help the U.S market towards a growth. The presence of major players will certainly prove beneficial for the market as with increasing research in finding out various applications of these bioreactors will certainly impact the market positively.

Apart from this, Washington Post reported that USA has the highest number of athletes in the Olympics. As continuous health monitoring plays an important role in athlete’s career, the presence of large number of athletes will positively drive the sales of EMG biosensors in this region.

Europe EMG Biosensors Market

Europe is the second most lucrative market owing to the European Union’s efforts to setup a novel technique in health monitoring. This technique is known as the Surface ElectroMyoGraphy for the Non-Invasive Assessment of muscles or SENIAM. EU’s Biomedical Health and Research P7rogramme has setup this technique. This technique consists of a set of simulation models for education and testing, a set of test signals, eight books, publications and a European network for SEMG: the SENIAM club.

Some of the Key player operating in Europe include; TMSi (Netherlands), Bitbrain Technologies (Spain), and LUX Wireless Biosignals S.A (Portugal).

Who are the key Manufacturing Supplying Companies in EMG Biosensors Market?

Key manufacturers and suppliers in the market are

• Biometrics Ltd. (US)
• Delsys Incorporated (US)
• Butler Technologies (Ireland)
• iMotions (Denmark)
• EB Neuro S.p.A. (Italy)
• Compumedics NeuroScan (United States)
• OpenBCI (US)
• Ceribell Inc. (United States) and others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

EMG Biosensors Market Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint.

Note: Although care has been taken to maintain the highest levels of accuracy in FMI’s reports, recent market/vendor-specific changes may time to reflect in the analysis.

For Complete TOC @ https://www.futuremarketinsights.com/toc/rep-gb-14216

Key Segment

By Type:

• Surface Biosensors
• Intramuscular Biosensors

By Technique:

• Signal Intensity Registration
• Pattern Recognition

By End User:

• Hospitals and Clinics
• Ambulatory Health Clinics
• Academic and Research Centres

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

The digital pathology market has witnessed notable changes in terms of product innovation. One of the major reasons behind this is the scope of cloud integration with pathology outcomes in laboratory operations. According to a recent report by Future Market Insights, the global digital pathology market was valued at USD 6.19 Bn in 2021 and is expected to witness a CAGR of 13.5% during the forecast period (2021 – 2031).